American Shared Hospital Services and U.S. Diagnostic succumbed to the inevitable last month, calling off talks regarding USDL's proposed acquisition of American Shared. American Shared cited USDL's inability to proceed with the negotiations in a timely
American Shared Hospital Services and U.S. Diagnostic succumbed to the inevitable last month, calling off talks regarding USDL's proposed acquisition of American Shared. American Shared cited USDL's inability to proceed with the negotiations in a timely fashion as the reason for the breakdown.
USDL of West Palm Beach, FL, and San Francisco-based American Shared first announced the proposed deal Dec. 11 (SCAN 12/18/96). USDL agreed to buy American Shared for $2.25 a share, payable in USDL stock, which was trading at around $12 a share when the deal was announced. USDL later increased the bid to $2.40 a share.
Two weeks later, however, revelations surfaced about the criminal record of USDL mergers and acquisitions consultant Keith Greenberg of Coyote Consulting. USDL's stock subsequently tanked, falling as low as $5.38. It has since rebounded, trading at around $8.75 last week. But that's still not high enough to make the deal attractive to USDL, according to CEO Joseph Paul.
American Shared will continue to entertain "expressions of interest" in the company, according to chairman and CEO Dr. Ernest Bates. The company will also pursue growth in its core business, as well as potential acquisitions, he said.
In addition to the USDL news, American Shared posted first-quarter financial results that indicated revenues of $9.1 million, up 2% compared with sales of $8.9 million in the first quarter of 1996. The company had net income of $39,000, compared with a net loss of $480,000.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
2 Commerce Drive
Cranbury, NJ 08512